Marsdenia tenacssima extract and its functional components inhibits proliferation and induces apoptosis of human Burkitt leukemia/lymphoma cells in vitro and in vivo.
Burkitt lymphoma is a fast growing non-Hodgkin lymphoma that occurs primarily in young males. The causes of Burkitt lymphoma include chromosome rearrangement and virus infection, but accurate and complete reasons remain to be discovered. The available treatment for Burkitt lymphoma is chemotherapy and radiation therapy. It is a highly aggressive B-cell neoplasm with not all patients cured, in spite of current therapies. This study evaluated the effects of traditional Chinese medicine Marsdenia tenacssima (MTE) and its component compound Tenacigenoside A (TGTA) and 11α-O-benzoyl-12β-O-acetyltenacigenin B (TGTB) on human Burkitt lymphoma growth. It was observed that MTE, TGTA or TGTB inhibited cell growth and induced apoptosis of Burkitt lymphoma cells in culture. In lymphoma bearing NOD/SCID nude mice, both TGTA and TGTB inhibited tumor growth and improved animal survival. TGTA and TGTB significantly increased tumor cell apoptosis on lymphoma bearing mice, primarily through down-regulation of BCL2 and BCL-XL and up-regulation of BID.
a Department of Hematology , Nanjing Benq Medical Center, Nanjing Medical University , Nanjing, Jiangsu Province , PR China.
Dong
D
Li
a Department of Hematology , Nanjing Benq Medical Center, Nanjing Medical University , Nanjing, Jiangsu Province , PR China.
Cuiping
C
Li
a Department of Hematology , Nanjing Benq Medical Center, Nanjing Medical University , Nanjing, Jiangsu Province , PR China.
Yanzhi
Y
Song
a Department of Hematology , Nanjing Benq Medical Center, Nanjing Medical University , Nanjing, Jiangsu Province , PR China.
Min
M
Zhou
b Division of Hematology, Department of Medicine , Jiangsu Provincial Traditional Chinese Medical Hospital , Nanjing, Jiangsu Province , PR China.
Xuemei
X
Sun
b Division of Hematology, Department of Medicine , Jiangsu Provincial Traditional Chinese Medical Hospital , Nanjing, Jiangsu Province , PR China.
Xuejun
X
Zhu
a Department of Hematology , Nanjing Benq Medical Center, Nanjing Medical University , Nanjing, Jiangsu Province , PR China.
Fan
F
Zhang
a Department of Hematology , Nanjing Benq Medical Center, Nanjing Medical University , Nanjing, Jiangsu Province , PR China.
Chen
C
Zhou
a Department of Hematology , Nanjing Benq Medical Center, Nanjing Medical University , Nanjing, Jiangsu Province , PR China.
Yahong
Y
Huan
a Department of Hematology , Nanjing Benq Medical Center, Nanjing Medical University , Nanjing, Jiangsu Province , PR China.
Suqin
S
Xia
a Department of Hematology , Nanjing Benq Medical Center, Nanjing Medical University , Nanjing, Jiangsu Province , PR China.
Xingli
X
Zhuo
a Department of Hematology , Nanjing Benq Medical Center, Nanjing Medical University , Nanjing, Jiangsu Province , PR China.
Ping
P
Dong
a Department of Hematology , Nanjing Benq Medical Center, Nanjing Medical University , Nanjing, Jiangsu Province , PR China.
Xuemei
X
Sui
a Department of Hematology , Nanjing Benq Medical Center, Nanjing Medical University , Nanjing, Jiangsu Province , PR China.
Haiying
H
Liao
c Division of Hematology/Oncology, Department of Medicine , University of Massachusetts Medical School , Worcester , MA , USA.
Zhong-Fa
ZF
Yang
BCL-XL; BCL2; BID; Burkitt leukemia; Marsdenia tenacssima; Raji cells; Tenacigenoside A; lymphoma; tenacigenin B